BOP2: Bayesian optimal design for phase II clinical trials with simple and complex endpoints (Q6997534)
From MaRDI portal
!
This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use the normal view instead:
scientific article; zbMATH DE number 8026961
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | No label defined |
||
| English | BOP2: Bayesian optimal design for phase II clinical trials with simple and complex endpoints |
scientific article; zbMATH DE number 8026961 |
Statements
BOP2: Bayesian optimal design for phase II clinical trials with simple and complex endpoints (English)
0 references
14 April 2025
0 references
Bayesian adaptive design
0 references
early stopping
0 references
ordinal endpoint
0 references
co-primary endpoints
0 references
immunotherapy
0 references
0 references
